Positive results from Phase II trial for Alzheimer’s

Positive results from Phase II trial for Alzheimer’s

Axon Neuroscience announces positive results from Phase II trial for a cure to Alzheimer’s Disease – Alzheimer’s Society comments.  On 9th September 2019, Axon Neuroscience has announced the results of the Phase II trial for AADvac1, its first-in-class vaccine aimed...
Moving more may reduce dementia risk

Moving more may reduce dementia risk

Moving more in old age may protect brain from dementia – Alzheimer’s Society comments.  A study by Rush University Medical Centre, published today in Neurology, suggests that older adults who move more than average – either in the...
We need to get better at diagnosing dementia

We need to get better at diagnosing dementia

A study published today in Neurology Clinical Practice found that brief cognitive tests, used in primary care settings to evaluate memory and thinking in order to identify whether people are likely to have dementia, may often be wrong.  Researchers found that...